Results 1-5 of 5 (Search time: 0.004 seconds).
Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link | |
---|---|---|---|---|---|---|---|
1 | 2021 | Fibrosis in Patients with Chronic Hepatitis B and Minimally Raised ALT during Tenofovir Therapy – Authors’ reply | YC Hsu; YT Huang ; JT Lin | LANCET INFECTIOUS DISEASES 21(7), 911 | |||
2 | 2021 | Application of Risk Scores for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: Current Status and Future Perspective | YC Hsu; CH Tseng; YT Huang ; HI Yang | Seminars in liver disease 41(03), 285-297 | |||
3 | 2021 | Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial | YC Hsu; CY Chen; IW Chang; CY Chang; CY Wu; TY Lee; MS Wu; MJ Bair; JJ Chen; CC Chen; CH Tseng; CM Tai; YT Huang ; WH Ku; LR Mo; JT Lin | LANCET INFECTIOUS DISEASES 21(6), 823-833 | |||
4 | 2020 | Editorial: risk assessment for chronic hepatitis B patients in the immune tolerant phase—both definition and selection matter | YC Hsu; YT Huang | Alimentary Pharmacology & Therapeutics 52(1), 213-214 | |||
5 | 2020 | Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis B | YC Hsu; GLH Wong; CH Chen; CY Peng; ML Yeh; KS Cheung; H Toyoda; CF Huang; H Trinh; Q Xie; M Enomoto; L Liu; S Yasuda; Y Tanaka; R Kozuka; PC Tsai; YT Huang ; C Wong; R Huang; TY Jang; J Hoang; HI Yang ; J Li; DH Lee; H Takahashi; JQ Zhang; E Ogawa; C Zhao; C Liu; N Furusyo; Y Eguchi; C Wong; C Wu; T Kumada; MF Yuen; ML Yu; M Nguyen | American Journal of Gastroenterology 115(2), 271-280 |